Endocrinology Center of New Jersey

91 East Front Street, Red Bank, NJ 07701

732-788-6365
Your Subtitle text
Thyroid,, Parathyroids,, Pituitary,, Adrenal Glands,,
and Bone Metabolism


Svetlana Shifrin-Douglas,MD
Board Certified
Endocrinologist



91 E Front Street
RED BANK, NJ 07701

tel:(732)788-6365
fax (732)230-7656

Accepting New patients.
Open on Saturdays



 
Dr Shifrin-Douglas is Board Certified Endocrinologist with more than 10 years of clinical experience.


Affiliations:
-Jersey Shore University Medical Center.
-Riverview Hospital.
-Monmouth Medical Center-
press release

Providing consultation and treatment for an adults with following Endocrine problems: 

                   


                     Thyroid Gland:

  • Multinodular goiter
  • Thyroid nodule
  • Thyroid cancer (papillary, follicular, Hurthle cell, medullary, anaplastic) 
  • Hashimoto's thyroiditis

In people with Hashimoto's hypothyroidism occurs at a rate of 4.3% per year versus 2.6% per year who do not have Hashimoto's.
Evaluation for Hashimoto's should be considered when evaluating patients with recurrent miscarriage, with or without infertility.

  • Hypothyroidism
  • Subclinical hypothyroidism
  • Hyperthyroidism (Graves' disease, toxic nodules),
  • Correction of thyroid function during pregnancy,
  • Correction of thyroid function during work-up for infertility and IVF treatment.

 

                   


Parathyroid Glands
  (abnormal calcium level):

  • Primary hyperparathyroidism
  • Secondary hyperparathyroidism
  • Tertiary hyperparathyroidism
  • Hypoparathyroidism after surgery
  • Congenital hypoparathyrodism




                Pituitary Gland:

  • Dysfunction
  • Prolactinoma
  • Cushing's Disease
  • Functional evaluation of pituitary tumors
  • Hypogonadism (low testosterone)

 



                        Adrenal glands
 

  • Functional evaluation of adrenal tumors
  • Cortisol dysfunction
  • Adrenal insufficiency
  • Cushing's syndrome 
  • Pheochromocytoma
  • Hyperaldosteronism (primary aldosteronism)
  • Virilizing tumors (men hormone secreating tumors)

 

 


                             Bone Metabolism:

  • Osteoporosis
  • Osteopenia
  • Vitamin D deficiency
  • Paget's disease             

 

                                                      

                           

Genetic Endocrine Syndroms:

 

  • Multiple Endocrine Neoplasia Type 1 (MEN 1)
  • Multiple Endocrine Neoplasia Type 2A and 2B (MEN 2A and MEN 2B)
  • Familial Medullary Thyroid Carcinoma Syndrome (FMTC)
  • Familial Hypocalciuric Hypercalcemia (FHH)

 
                                                    
 
                   Pregnancy and Infertility
  • Hypothyroidism
  • Hyperthyroidism
  • Hashimoto's thyroiditis
  • Prolactinoma

Overt untreated hypothyroidism during pregnancy may adversely affect maternal and fetal outcomes. These adverse outcomes include increased incidences of spontaneous miscarriage, preterm delivery, preeclampsia, maternal hypertension, postpartum hemorrhage, low birth weight and stillbirth, and impaired intellectual and psychomotor development of the fetus.

 

Women with positive TPOAb may have an increased risk for first trimester miscarriage, preterm delivery, and for offspring with impaired cognitive development.

 

It is important to have normal thyroid function prior to conceiving.

 

Requirements of thyroid hormone increase during pregnancy.

 

When a woman with hypothyroidism becomes pregnant, the dosage of L-thyroxine should be increased as soon as possible.

Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association 

"Treatment with L-thyroxine should be considered in women of childbearing age with normal serum TSH levels when they are pregnant or planning a pregnancy, including assisted reproduction in the immediate future, if they have or have had positive levels of serum TPOAb, particularly when there is a history of miscarriage or past history of hypothyroidism."

 

"Women of childbearing age who are pregnant or planning a pregnancy, including assisted reproduction in the immediate future, should be treated with L-thyroxine if they have or have had positive levels of serum TPOAb and their TSH is greater than 2.5 mIU/L."


Metabolism and Obesity

  • PCOS
  • The World Health Organization estimates that PCOS affects 116 million women worldwide as of 2010 (3.4% of the population).

  • Endocrine evaluation of obesity and fatigue 

  • Do you struggle with weight gain or obesity? Have you been dieting and exercising, but unable to loose weight?

    It would be important to be evaluated for Endocrine cause of obesity.

    Did you know that several endocrine abnormalities, including Hypothyroidism, Cushing’s, Polycystic ovary syndrome (PCOS), Subclinical Hypothyroidism are considered as causative factors of obesity?

    Prevalence in obesity of Cushing’s 1%, metabolic syndrome 40%,PCOS 12%, Hypothyroidism 5%, Hashimoto 11%.